Sign in Sign up for free

QSAM Biosciences Revenue

What is the Revenue of QSAM Biosciences?

The Revenue of QSAM Biosciences, Inc. is $0.00

What is the definition of Revenue?



Revenue is the income that a business has from its normal business activities, usually from the sale of goods and services to customers.

ttm (trailing twelve months)

Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.

In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.

Revenue of companies in the Health Care sector on OTC compared to QSAM Biosciences

What does QSAM Biosciences do?

QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.

Companies with revenue similar to QSAM Biosciences